Hayden E. Klein

If payers can agree on consensus criteria to improve care quality or costs, that will help physicians remember and try to be compliant, said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.

The pilot 4T study showed consistent hemoglobin A1C improvement in all children with type 1 diabetes (T1D) after 1 year, underscoring the importance of early continuous glucose monitoring (CGM) following diagnosis, explained David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital.

The Respiratory Infection Intensity and Impact Questionnaire (RiiQ) Symptoms Scale demonstrated logical patterns of upper and lower respiratory symptoms among participants.

In a review of adults with type 1 diabetes (T1D), having a body mass index (BMI) <18.5 kg/m2 increased the risk of all-cause mortality by 3.4 times compared with normal BMI.

Among women on Medicaid, the prevalence of Kaposi sarcoma—a cancer commonly associated with HIV—was 82 times higher in women with HIV compared with women without HIV.

"It's really important that oncologists are on level footing along with the rest of their medical peers," said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.

According to new estimates, the US government spent between $143 million and $314 million in 2022 inflation-adjusted dollars funding the development of tenofovir disoproxil fumarate-emtricitabine. The previous estimate was around $50 million.

Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.

Individuals with type 1 diabetes (T1D) had brain atrophy patterns equivalent to a brain age about 6 years older than their actual age.

The study also showed that the measurement of HbA1c—which serves as an indicator of clinical assessment—sharply drops in the late teenage years among individuals with type 1 diabetes (T1D).

In a case report, dupilumab and prednisone were among the treatments for atopic dermatitis (AD) used to relieve a patient of her delayed generalized hypersensitivity reaction to the mRNA COVID-19 vaccine.

A review of 24 meta-analyses supported the need for additional monitoring of patients with diabetes and COVID-19, especially if they have comorbidities associated with diabetes.

A CDC report emphasized the need for increased investments, innovation, and focus on equity in order to end the HIV epidemic.

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, the strategy advancement lead at Humana talked more about Humana’s health equity strategy and areas that pharmacy benefit managers (PBMs) and health plans can influence.

Telehealth provides more flexibility for patients with gastrointestinal issues to better fit their care into their lives and around symptoms they may be experiencing, said Sam Holliday, co-founder and CEO of Oshi Health.

Having at least 2 episodes of severe hypoglycemia that required hospitalization was found to be a major predictor for time to death in individuals with type 1 diabetes (T1D).

Between 2010 and 2020, pediatric antiretroviral therapy (ART) coverage tripled, but still consistently lagged behind adult ART coverage.

Pharmacists at the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting discussed the role of data collection and analysis in the movement toward health equity.

David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital, highlights key points from his review on pediatric diabetes technology and therapy.

Joel Segel, PhD, associate professor of health policy and administration at Penn State University, talks about what he's looking forward to as a member of The American Journal of Accountable Care's editorial board.

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).

Panelists from Optum Life Sciences, OptumRx, and Takeda discussed the importance of collaboration in creating successful value-based agreements (VBAs) at Asembia 2023.

“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.

Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.

In a cohort of patients in New York with mpox, HIV status did not seem to affect treatment outcomes with tecovirimat, although more research is needed.

A panel at Asembia 2023 discussed what their organizations are doing to improve diversity, equity, and inclusion (DEI) at their organizations, and what others can learn from these efforts.

At the first business session of Asembia 2023, Ray Tancredi, divisional vice president at Walgreens, provided updates to the 2023 specialty therapy pipeline.

New research suggests that racial residential segregation is associated with glycemic control among Black youth with type 1 diabetes.

Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study.

A recent study found that HIV is 2.5 times more common in people who use mental health services compared with the general population in South London.